CCL20 Protein (AA 27-96)
Quick Overview for CCL20 Protein (AA 27-96) (ABIN2018253)
抗原
See all CCL20 蛋白蛋白类型
生物活性
宿主
资源
纯度
-
-
产品特性
- AA 27-96
-
产品特性
- The EC50 value of humanMIP-3 alpha/CCL20 on Ca2+ mobilization assay in CHO-K1/Ga15/hCCR6 cells (human Ga15 and human CCR6 stably expressed in CHO-K1 cells) is less than 200 ng/mL.
-
内毒素水平
- < 0.2 EU/μg, determined by LAL method.
-
-
Chemokine (C-C Motif) Ligand 20 (CCL20) protein (His tag)
CCL20 宿主: 人 宿主: 人细胞 Recombinant >95 % as determined by reducing SDS-PAGE.
Chemokine (C-C Motif) Ligand 20 (CCL20) (AA 27-96) protein (His tag)CCL20 宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant > 95 % as determined by Tris-Bis PAGE
Chemokine (C-C Motif) Ligand 20 (CCL20) (AA 27-95) protein (GST tag)CCL20 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AP, AA
-
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstituted in ddH2O or PBS at 100 μg/mL.
-
缓冲液
- Lyophilized after extensive dialysis against PBS.
-
储存条件
- -80 °C
-
储存方法
- Lyophilized recombinant Human MIP-3 alpha/CCL20 remains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, Human MIP-3 alpha/CCL20 should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
-
有效期
- 6 months
-
-
- CCL20 (Chemokine (C-C Motif) Ligand 20 (CCL20))
-
别名
- MIP-3 alpha/ccl20
-
背景
-
Chemokine (C-C motif) ligand 20 (CCL20) also known as liver activation regulated chemokine (LARC) or Macrophage Inflammatory Protein-3 (MIP3 alpha) is a small cytokine belonging to the CC chemokine family. It is strongly chemotactic for lymphocytes and weakly attracts neutrophils. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors.Recombinant humanMIP-3 alpha/CCL20 produced in CHO cells is a polypeptide chain containing 70 amino acids. A fully biologically active molecule, rhMIP-3 alpha/CCL20 has a molecular mass of 8 kDa analyzed by reducing SDS-PAGE.
Synonyms: MIP-3 alpha/CCL20, Human -
分子量
- 8 kDa, observed by reducing SDS-PAGE.
-
UniProt
- P78556
-
途径
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
抗原
-
